Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Accured Expenses (2020 - 2025)

LifeStance Health (LFST) has disclosed Change in Accured Expenses for 6 consecutive years, with -$69000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 101.45% to -$69000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.9 million, a 139.54% decrease, with the full-year FY2025 number at -$5.9 million, down 139.54% from a year prior.
  • Change in Accured Expenses was -$69000.0 for Q4 2025 at LifeStance Health, up from -$17.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $26.5 million in Q4 2021 to a low of -$17.6 million in Q3 2025.
  • A 5-year average of $3.0 million and a median of $3.0 million in 2023 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 593.54% in 2025; the steepest drop was 442.64% in 2025.
  • LifeStance Health's Change in Accured Expenses stood at $26.5 million in 2021, then crashed by 165.12% to -$17.3 million in 2022, then surged by 114.98% to $2.6 million in 2023, then surged by 83.83% to $4.8 million in 2024, then plummeted by 101.45% to -$69000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Change in Accured Expenses are -$69000.0 (Q4 2025), -$17.6 million (Q3 2025), and $16.1 million (Q2 2025).